XML 69 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Aug. 31, 2014
Aug. 31, 2013
Cash flows from operating activities:    
Net loss $ (65,548) $ (11,847)
Adjustments to reconcile net income to net cash used in operating activities:    
Equity in income (loss) of unconsolidated joint venture (872) 577
Distributions of earnings from unconsolidated joint ventures 0 1,638
Amortization of discounts and issuance costs 5,246 3,811
Depreciation and amortization 1,677 1,405
Stock-based compensation 5,959 3,596
Inventory impairments and land option contract abandonments 5,211 284
Change in assets and liabilities:    
Receivables (27,754) (7,001)
Inventories (784,457) (491,002)
Accounts payable, accrued expenses and other liabilities 20,388 72,315
Other, net (7,608) 1,071
Net cash used in operating activities (716,662) (401,459)
Cash flows from investing activities:    
Return of investments in (contributions to) unconsolidated joint ventures (34,034) (10,056)
Proceeds from Sale of Equity Method Investments 10,110 0
Purchases of property and equipment, net (4,158) (1,359)
Net cash provided by (used in) investing activities (28,082) (11,415)
Cash flows from financing activities:    
Change in restricted cash 9,450 731
Proceeds from issuance of debt 400,000 230,000
Payment of debt issuance costs (5,448) (10,086)
Payments on mortgages and land contracts due to land sellers and other loans (23,292) (44,405)
Proceeds from issuance of common stock, net 137,045 109,503
Issuance of common stock under employee stock plans 202 2,147
Payments of cash dividends (6,682) (6,272)
Payments for Repurchase of Common Stock (46) (7,967)
Net cash provided by (used in) financing activities 511,229 273,651
Net increase (decrease) in cash and cash equivalents (233,515) (139,223)
Cash and cash equivalents at beginning of period 532,523 525,688
Cash and cash equivalents at end of period $ 299,008 $ 386,465